Showing 1 - 8 of 8
Demographic change will be one of the major challenges for economic policy in the developed world in the next decades. In this article, we analyze the relationship between age structure and the number of startups. We argue that an individual's decision to start a business is determined by his or...
Persistent link: https://www.econbiz.de/10010264224
Bavarian State Government. The purpose of the initiative was to create a Bavarian-wide innovation network in support of state … the likelihood of innovation by a firm in the targeted industry by 4 to 7 percentage points. However, this effect is …
Persistent link: https://www.econbiz.de/10010264488
Keeping up with rapid technological change necessitates constant innovation. Successful innovation depends on both … implement them. Both of these knowledge-based elements of innovation can be attained through moderate labor force turnover in … innovation within a multivariate regression framework. However, when instrumenting training by the existence of a union …
Persistent link: https://www.econbiz.de/10010264329
We use longitudinal, disease-level data to analyze the impact of pharmaceutical innovation on longevity and medical … expenditure in Sweden, where mean age at death increased by 1.88 years during the period 1997-2010. Pharmaceutical innovation is … the number of drugs to treat a disease, not the number of drug classes. Pharmaceutical innovation also reduced hospital …
Persistent link: https://www.econbiz.de/10010283600
A national-champions-related industrial policy has become (again) en vogue among European politicians. Against this background, our work orders different types of national champions along the industry lifecycle. Different types of locally bound externalities appear along the lifecycle. In a...
Persistent link: https://www.econbiz.de/10010264424
I investigate the contribution of pharmaceutical innovation to recent longevity growth in Germany and France. First, I …-2006. The estimates imply that chemotherapy innovation accounted for at least one-sixth of the decline in French cancer …
Persistent link: https://www.econbiz.de/10010270528
increased more in some states than in others?" One of the conclusions I drew from that study was that medical innovation …-Berman express deep skepticism about my study's conclusion that medical innovation has played a very important role in recent U …
Persistent link: https://www.econbiz.de/10010272883
Longitudinal, disease-level data are used to analyze the impact of pharmaceutical innovation on longevity (mean age at … pharmaceutical innovation increased mean age at death by 0.87 years (10.4 months)- about 44% of the total increase in longevity -and … pharmaceutical innovation. The baseline estimate of the cost per life-year gained from pharmaceutical innovation in Greece is $17 …
Persistent link: https://www.econbiz.de/10010480895